Lexicon Pharmaceuticals recently gained FDA approval for its heart failure and type 2 diabetes drug, Inpefa, and is marketing the drug aggressively. Lexicon's financials show mixed results, with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback